NCT01353625 / 2011-004558-24: Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. |
|
|
| Completed | 1a/1b | 118 | Europe, US | CC-115 | Celgene | Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer, Ewing's Osteosarcoma, Chronic Lymphocytic Leukemia, Neoplasm Metastasis | 03/21 | 03/21 | | |
